About me

Anna is the Chief Marketing Officer for Glanbia Performance Nutrition International, where she leads the end to end marketing agenda across International markets. Anna is passionate about health, wellness, and empowering people to become the best and healthiest versions of themselves. She oversees brand building, portfolio and innovation strategy, and winning omnichannel marketing execution across the brand portfolio, which includes the world's number 1 Sports Nutrition brand, Optimum Nutrition.

Previously, Anna served as CMO of Karo Healthcare, a Private Equity owned consumer healthcare business, whose brands include E45, Lamisil, and Nutravita. As a member of the Executive Committee she played a key role in shaping company strategy, operating model and culture, and in 2025, guiding the sale of the business to KKR. Under her leadership, E45 won Channel 4's Diversity in Advertising Award for the breakthrough campaign 'This is me. This is my space', recognised for its creative effectiveness and authentic representation.
Earlier in her career, Anna held Vice President and Senior Marketing Director positions at Haleon and Reckitt, leading Marketing, Brand & Innovation teams across the UK, Europe and APAC.

In 2024 and 2025, Anna was named in Marketing Week's Top 100 Marketeers.

Anna is also a Board Trustee of The Bridge, a women's health charity in Southwark, dedicated to improving access, support, and health equality for women in the community.

Skills

Advertising, Analysis, Brand Management, Brand Stategy, Branding, Business Management, Change Management, Consultancy, Digital Marketing, Digital Strategy, Internal Communications, Market Research, Marketing, Marketing Strategy, Product Development, Team Management

Sector Experience

Consumer Healthcare, FMCG, Healthcare

Recommendations
- 
Currently No Recommendations
Achievements
Annual 2025 JudgeAnimation Annual 2026 JudgeBest Brand to Work For
Tagged Job Titles
Contract
Perm
Location
London, United Kingdom
Skill Level
Director
Creativepool member since 7 February 2025